SAKAR HEALTHCARE
Back to Income Statement
|
SAKAR HEALTHCARE Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹153 Cr | ₹133 Cr | ₹128 Cr | ₹95 Cr | ₹8,298,024 Cr |
What is the latest Revenue of SAKAR HEALTHCARE ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹153 Cr |
| Mar2024 | ₹133 Cr |
| Mar2023 | ₹128 Cr |
| Mar2022 | ₹95 Cr |
| Mar2021 | ₹8,298,024 Cr |
How is Revenue of SAKAR HEALTHCARE Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹153 Cr | 14.99 | |
| Mar2024 | ₹133 Cr | 4.00 | |
| Mar2023 | ₹128 Cr | 35.35 | |
| Mar2022 | ₹95 Cr | -100.00 | |
| Mar2021 | ₹8,298,024 Cr | - | |
Compare Revenue of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹2,144.0 Cr | 7.1% | 4.7% | 160.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,180.0 Cr | 1.6% | -1% | 22.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹243,302.0 Cr | 1.7% | 10.1% | 49.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,623.0 Cr | 1.5% | -1.2% | 38.2% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | 0.7% | -3.5% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,741.0 Cr | -1.3% | 0.1% | -7.8% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | 7.1% |
4.7% |
160.1% |
| SENSEX | -0.9% |
-1.5% |
-5.8% |
You may also like the below Video Courses